col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

142 Results       Page 1

Elsevier: Journal of Cystic Fibrosis
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―14 Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis Athanasios Michos, Filippos Filippatos, Elisabeth-Barbara Tatsi, Charilaos Dellis, Vasiliki Efthymiou, Ioanna Zarkada, et al. (+3)
2 [GO] 2022―Feb―21 THE CLINICAL IMPACT OF THE COVID-19 PANDEMIC FIRST WAVE ON PATIENTS WITH CYSTIC FIBROSIS IN NEW YORK] Joseph L. Simonson, Christine Esposito, Theresa Frantzen, Katherine Henthorne, Aileen Espinal, Serena Romano, et al. (+27)
3 [GO] 2022―Feb―16 Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over Gianfranco Alicandro, Valeria Daccó, Lisa Cariani, Martina Contarini, Letizia Corinna Morlacchi, Chiara Rosazza, et al. (+7)
4 [GO] 2021―Dec―18 Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis Beth A. Smith, Anna M. Georgiopoulos, Amy Mueller, Janice Abbott, Paula Lomas, Enid Aliaj, Alexandra L. Quittner
5 [GO] 2021―Dec―18 Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis (Commentary) Trudy Havermans
6 [GO] 2021―Dec―18 Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic George M. Solomon, Julianna Bailey, James Lawlor, Peter Scalia, Gregory S. Sawicki, Christopher Dowd, et al. (+2)
7 [GO] 2021―Dec―18 Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic Christopher Dowd, Aricca D. Van Citters, Olivia Dieni, Anne Willis, Leslie Powell, Kathryn A. Sabadosa
8 [GO] 2021―Dec―18 Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs Alex H. Gifford, Thida Ong, Christopher Dowd, Aricca D. Van Citters, Peter Scalia, Kathryn A. Sabadosa, Gregory S. Sawicki
9 [GO] 2021―Dec―18 Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future Gregory S. Sawicki, Aricca D. Van Citters, Olivia Dieni, Kathryn A. Sabadosa, Anne Willis, Debbie Benitez, et al. (+2)
10 [GO] 2021―Dec―18 Financial impacts of the COVID-19 pandemic on cystic fibrosis care: Lessons for the future (Commentary) A.L. Stephenson Anne L. Stephenson
11 [GO] 2021―Dec―18 Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members Aricca D. Van Citters, Olivia Dieni, Peter Scalia, Christopher Dowd, Kathryn A. Sabadosa, Jill D. Fliege, et al. (+3)
12 [GO] 2021―Dec―18 Impact of the COVID-19 pandemic: How our response is shaping the future of cystic fibrosis care Kathryn A. Sabadosa, Albert Faro, Eugene C. Nelson, Bruce C. Marshall
13 [GO] 2021―Dec―18 Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors Dana Albon, Aricca D. Van Citters, Thida Ong, Olivia Dieni, Christopher Dowd, Anne Willis, et al. (+5)
14 [GO] 2021―Dec―13 SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: a seroprevalence study in two specialized centres in Northern Italy Gianfranco Alicandro, Valeria Daccó, Lisa Cariani, Martina Contarini, Letizia Corinna Morlacchi, Chiara Rosazza, et al. (+6)
15 [GO] 2021―Nov―14 Management of Cystic Fibrosis during COVID-19: Patient Reported Outcomes based remote follow-up among CF patients in Denmark - A feasibility study Lotte Rodkjær, Majbritt Jeppesen, Liv Schougaard
16 [GO] 2021―Oct―19 76: Sustaining routine cystic fibrosis care in a large pediatric CF program during COVID-19 R. Gordon, K. Barnico, G. Sawicki, M. Harrison
17 [GO] 2021―Oct―19 152: Weekly patient-family-staff-volunteer during COVID-19 G. Raissi, N. Patel, R. Casey, B. Corcoran, H. Sadeghi
18 [GO] 2021―Oct―19 335: Greater access to mental health care with CF team psychologist through telemedicine during COVID-19 S. Filigno, E. Hente, M. Lisa, C. Siracusa
19 [GO] 2021―Oct―19 58: Seroprevalence of COVID-19 IgG in the cystic fibrosis population K. Mahan, J. Billings, S. Kiel, S. Sultan, J. Dunitz, B. Noren, et al. (+2)
20 [GO] 2021―Oct―19 346: Tennessee cystic fibrosis clinical care during the COVID-19 pandemic F. Cacho, S. Srinivasan, R. Schoumacher, R. Hamilton, J. Ledbetter, M. Moser, et al. (+8)
21 [GO] 2021―Oct―19 334: Addressing food insecurity and mental health during the COVID-19 pandemic L. Weaver, M. Reed, A. Chidekel
22 [GO] 2021―Oct―19 310: Physically distant but virtually together: CF community-based webcasts during the COVID-19 pandemic A. Uluer, S. Rits, C. Snell, M. Alao, I. Bailey, C. Huysman, et al. (+10)
23 [GO] 2021―Oct―19 296: Mental health implications of genetic modulator therapy in CF: Depression and anxiety screening for pediatric patients prescribed elexacaftor/tezacaftor/ivactor during the COVID-19 pandemic T. Vance, M. Finch, D. Bauer, M. Sachs, S. Landvik, J. McNamara
24 [GO] 2021―Oct―19 274: Creating a virtual CF support group for adolescents during the COVID-19 pandemic E. Jorgensen, Z. Held, S. Garcha, C. Courtlandt, D. Schellhase
25 [GO] 2021―Oct―19 269: Food security and nutritional adherence in adolescents with cystic fibrosis during the COVID-19 pandemic K. Durkin, J. Kelleher, L. Stark, K. Griffin, C. Lynn, S. Filigno, et al. (+4)
26 [GO] 2021―Oct―19 239: Perspectives of people with CF and caregivers regarding medication access and telehealth in CF care during the COVID-19 pandemic H. Phan, E. Hall Lipsy, K. McCulley, E. Vuong, K. Anderson, A. Sharpe, A. Bowen
27 [GO] 2021―Oct―19 188: Cystic fibrosis kidney stone disease in the era of CFTR modulator use and the COVID-19 pandemic S. Romano, T. Frantzen, G. LaVecchia, J. Wang
28 [GO] 2021―Oct―19 177: Impact of elexacaftor/tezacaftor/ivacaftor therapy use on pulmonary exacerbation rates during the COVID-19 pandemic E. Menten, T. Saroya, E. DiMango, C. Keating
29 [GO] 2021―Oct―19 166: Reliability of a home spirometer for monitoring children with cystic fibrosis during the COVID-19 pandemic D. Mager, C. James-Boldewijn, D. Archangel, S. Lever, H. Janssens
30 [GO] 2021―Oct―19 113: Addressing food insecurity among patients with CF during the COVID-19 pandemic W. Sewell, D. Sadeghi, G. Raissi, B. Corcoran, H. Sadeghi
31 [GO] 2021―Oct―19 110: Real-world outcomes in cystic fibrosis telehealth clinical care during the COVID-19 pandemic L. Somerville, R. List, M. Compton, H. Bruschwein, D. Jennings, R. Murray, et al. (+5)
32 [GO] 2021―Oct―19 107: A new statewide consortium of cystic fibrosis care centers formed during the COVID-19 pandemic S. Srinivasan, R. Brown, J. Ledbetter, D. Quintero
33 [GO] 2021―Oct―19 83: CF Global Care: Continuation of the collaboration between 2 CF centers; University of Michigan, USA, and Marmara University, Istanbul, Turkey, in the COVID-19 pandemic S. Nasr, Y. Gökdemir, E. Erdem Eralp, F. Karakoc, P. Ergenekon, C. Tapley, et al. (+5)
34 [GO] 2021―Oct―19 79: A patient satisfaction survey regarding the use of telemedicine for outpatient CF endocrinology and diabetes care during the COVID-19 pandemic S. Soltman, D. Gardner, A. Swift
35 [GO] 2021―Oct―19 14: Pregnancy and outcomes in the era of CFTR modulators and COVID-19 pandemic S. Li, A. Patel, J. Heintz, A. Nance, A. Rice, K. Sakellaris, et al. (+5)
36 [GO] 2021―Oct―19 44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study S. Cheng, T. Le, M. McIlwaine, I. McIntosh, J. Wallenburg, A. Stephenson
37 [GO] 2021―Oct―19 314: The COVID-19 pandemic and trends in anxiety and depressive symptoms in adolescents with cystic fibrosis and their caregivers S. Szentpetery, K. Foil, L. Christon
38 [GO] 2021―Oct―19 71: Collection of expectorated sputum or oral pharyngeal cultures during initial period of the COVID-19 pandemic in a pediatric cystic fibrosis clinic J. Hamilton, S. Meihls, H. Toledo, A. Snuggerud, S. Spade Warren
39 [GO] 2021―Oct―19 333: Perceptions of telehealth of patients with cystic fibrosis and their caregivers during the COVID-19 pandemic in Australia R. Ruseckaite, J. Herdiman, S. Ahern
40 [GO] 2021―Oct―19 276: Effects of COVID-19 pandemic on adult cystic fibrosis patients’ mental health P. Chen, D. Finklea, L. Cohen, R. Jain, K. Lowe, G. Ratti, et al. (+2)
41 [GO] 2021―Oct―19 41: COVID-19 pandemic restrictions have long-term impact on physical activity in adults with cystic fibrosis T. Radtke, S. Haile, H. Dressel, C. Benden
42 [GO] 2021―Oct―19 131: Home spirometry utilization in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: A quality improvement process M. Compton, R. List, E. Starheim, L. Williamson, D. Jennings, L. Gettle, et al. (+4)
43 [GO] 2021―Oct―19 266: Physiotherapy during the COVID-19 pandemic: Support for the shielding patient by the shielding physiotherapist J. Carson, L. Alexander, J. Bell
44 [GO] 2021―Oct―19 235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center E. Elson, E. Meier, P. Capel, J. Haynes, M. Fischer, S. Duehlmeyer, C. Oermann
45 [GO] 2021―Oct―19 54: Evaluating COVID-19 Vaccine Hesitancy at the New Orleans Adult CF Care Center J. Bodnar, E. Sheffield, R. Klingsberg, C. Bojanowski
46 [GO] 2021―Oct―19 340: Challenges in obtaining COVID-19 vaccines: Bridging the gap for rural northeast Texas cystic fibrosis patients C. Guthrie, T. Sadler, C. Wadle, E. Dohanich, L. Couch
47 [GO] 2021―Oct―19 337: Food insecurity in the cystic fibrosis care center network during COVID-19: Prevalence, screening, and interventions J. Bailey, G. Brown, M. Corbera-Hincapie, C. Clemm, E. Dasenbrook, D. Durham, et al. (+5)
48 [GO] 2021―Oct―19 336: Compass trends and the potential impact of coronavirus R. Scott, B. McCreery-Cullifer, K. Muldowney, A. Stocks, A. Kaider
49 [GO] 2021―Oct―19 416: Expression of SARS-CoV-2 entry genes is not greater in the nasal mucosa of CF patients M. Sala, N. Markov, A. Misharin, M. Jain
50 [GO] 2021―Oct―19 382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins A. Recchiuti, S. Patruno, D. Mattoscio, E. Isopi, A. Pomilio, R. Pecce, M. Romano
51 [GO] 2021―Oct―19 496: Reduced susceptibility of mice with CF-like lung disease to SARS-CoV-2 infection P. Hawkins, K. Okuda, S. Leist, A. Schafër, R. Gilmore, A. Volmer, et al. (+6)
52 [GO] 2021―Oct―19 25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis G. Hergenroeder, J. Cogen, A. Genatossio, S. McNamara, M. Pascual, R. Hernandez
53 [GO] 2021―Oct―19 159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis T. Kremer, I. St Onge, M. Trivedi, F. Dy, C. Bielick, D. Fish, et al. (+3)
54 [GO] 2021―Oct―19 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study A. Blanchard, S. Hewko, R. Somayaji, J. Cogen, R. Hernandez, A. Stephenson, et al. (+6)
55 [GO] 2021―Oct―19 433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study R. Hernandez, J. Cogen, A. Blanchard, V. Waters, D. Downey, L. Hoffman, et al. (+10)
56 [GO] 2021―Oct―19 515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF S. Nakano, K. Okuda, C. Edwards, H. Dang, T. Asakura, T. Kato, et al. (+12)
57 [GO] 2021―Oct―19 410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2 M. Ruffin, J. Bigot, C. Calmel, J. Mercier, A. Pizzorno, M. Rosa-Calatrava, et al. (+4)
58 [GO] 2021―Oct―19 343: Impact of the SARS-CoV-2 pandemic and a food pantry on food insecurity in a pediatric cystic fibrosis center H. Holzum, K. Nelson, J. Granneman, J. Acton, R. Nevel
59 [GO] 2021―Oct―19 156: Pre-procedural Sars-CoV-2 testing and pulmonary function testing I. St Onge, F. Dy, M. Trivedi, J. Longtine, K. Longtine, D. Fish, et al. (+3)
60 [GO] 2021―Oct―19 81: Maintaining routine cystic fibrosis sputum surveillance during the pandemic J. Seguin, J. Cary, T. Hatch, P. Scharoun, A. Grzymkowski, C. Fortner, et al. (+2)
61 [GO] 2021―Oct―19 61: Improving CFRD screening in a pediatric CF center during a pandemic J. Stewart, A. Snuggerud, S. Meihls, S. Spade Warren, H. Toledo, F. Asfour
62 [GO] 2021―Oct―19 299: Stress and mental health in cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample S. Graziano, F. Boldrini, V. Lucidi, P. Tabarini
63 [GO] 2021―Oct―19 344: Initiating food insecurity screening during a pandemic: Identifying and overcoming barriers J. Fulton, M. Koons, H. Torres, A. Gray, S. Martin, J. Hoppe
64 [GO] 2021―Oct―19 338: A serendipitous role of telehealth in postpandemic CF care J. Makhija, S. Samantha, C. Forseen, V. Taskar, J. Yap
65 [GO] 2021―Sep―24 Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care J Stuart Elborn
66 [GO] 2021―Sep―11 Telehealth after the pandemic: Will the inverse care law apply? Rebecca J Calthorpe, Alan R. Smyth
67 [GO] 2021―Sep―02 Commentary on: “Evaluating barriers and promotors of telehealth during the COVID-19 pandemic at cystic fibrosis programs to inform new models of CF care” Sarath C. Ranganathan
68 [GO] 2021―Jun―11 P088 Impact of COVID-19 and cocooning on employment of people with cystic fibrosis R. Bhatnagar, S. Tecklenborg, R. Segurado, P. Fitzpatrick
69 [GO] 2021―Jun―11 P179 Has COVID-19 affected the management of vitamin D status amongst people with cystic fibrosis? A. Ochota, S. Pandya, M. Walshaw
70 [GO] 2021―Jun―11 P227 Cystic fibrosis social workers’ experience of working during COVID-19 F. Dowdall, A. Tansinda, M. Donnelly, S. Chandran
71 [GO] 2021―Jun―11 EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis E. Hatziagorou, P. Peftoulidou, I. Toulia, E. Tasika, E.-A. Chrysochoou, J. Tsanakas
72 [GO] 2021―Jun―11 EPS1.04 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis Z. Johnstone, J. Hyson
73 [GO] 2021―Jun―11 P089 Coronavirus infection (COVID-19) in children with cystic fibrosis of the Russian Federation E. Kondratyeva, A. Gorelov, E. Zhekaite, S. Nikolaeva, V. Sherman, O. Simonova, et al. (+4)
74 [GO] 2021―Jun―11 P137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort C. Steinack, R. Hage, F. Gautschi, M.M. Schuurmans
75 [GO] 2021―Jun―11 P208 Anxiety, depression and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregivers M. Verkleij, L. Noij, S. Hashimoto, S. Terheggen-Lagro, J. Altenburg, E. Haarman
76 [GO] 2021―Jun―11 P086 The impact of COVID-19 in people with cystic fibrosis - a single-centre experience G. Aldous, N. Pinnock, D. Nazareth, M. Walshaw
77 [GO] 2021―Jun―11 P136 Relationship between cystic fibrosis disease severity and susceptibility to COVID-19 infection M. Atalay, N. Emiralioĝlu, U. Özçelik, E. Yalçın, D. Doĝru, N. Kiper, D. Dayangaç Erden
78 [GO] 2021―Jun―11 EPS2.07 How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland? M. Mielus, M. Surowiecka, P. Madej, K. Zybert, D. Sands
79 [GO] 2021―Jun―11 EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics E. Scott, M. Ledson, M. Walshaw
80 [GO] 2021―Jun―11 P085 Impact of COVID-19 on hospital services and specialist care of adults with cystic fibrosis R. Bhatnagar, S. Tecklenborg, R. Segurado, P. Fitzpatrick
81 [GO] 2021―Jun―11 P087 Impact of COVID-19 on mental health of children with cystic fibrosis and their parents R. Bhatnagar, S. Tecklenborg, R. Segurado, P. Fitzpatrick
82 [GO] 2021―Jun―11 EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK C. Brown, M. Archer, L. Carson, N. Collins, T. Daniels, A. Gates, et al. (+4)
83 [GO] 2021―Jun―11 P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team S. Jones, L. Smith, K. Ainsworth
84 [GO] 2021―Jun―11 P229 Children and young people with cystic fibrosis enhanced multidisciplinary pathways to address their educational needs during the evolving COVID-19 pandemic S. Chandran, M. Panayi
85 [GO] 2021―Jun―11 P230 A review of paediatric cystic fibrosis care during the COVID-19 pandemic L. Powell, J. Watkinson, N. Rao
86 [GO] 2021―Jun―11 P226 A survey of family experience of cystic fibrosis care during the COVID-19 pandemic J. Watkinson, L. Powell, N. Rao
87 [GO] 2021―Jun―11 P225 Parents’ feedback on virtual paediatric cystic fibrosis clinics during COVID-19 pandemic M. Powell, R. Rees, L. John, R. Street, R. Evans
88 [GO] 2021―Jun―11 P218 Detection of anxiety and depression through mental health screening questionnaires in cystic fibrosis patients and their families during the COVID-19 pandemic A. Morales Tirado, E. Blitz Castro, S. Vicente Santamaría, A. Lamas Ferreiro, M.F. Pando, P. Fernández Martín, et al. (+6)
89 [GO] 2021―Jun―11 P211 Use of telemedicine for mental health screening during the COVID-19 pandemic H. Bruschwein, M. Soper, D. Jennings, L. Somerville, R. List, M. Compton, et al. (+4)
90 [GO] 2021―Jun―11 P172 Patient experience of Manchester Virtual Cystic Fibrosis-Related Diabetes Clinic during the COVID-19 pandemic A. Brennan, J. Pickles, S. Punt, K. Taylor, J. Beynon
91 [GO] 2021―Jun―11 P157 Monitoring the distribution and genotypic diversity of Burkholderiales bacteria in Russian cystic fibrosis patients in the year of the COVID-19 pandemic O. Voronina, N. Ryzhova, M. Kunda, E. Aksenova, A. Lasareva, O. Simonova, et al. (+3)
92 [GO] 2021―Jun―11 P138 Rapid implementation of virtual clinics during the COVID-19 pandemic D. Nazareth, C. Sumner, M. Walshaw
93 [GO] 2021―Jun―11 P094 Facilitating cystic fibrosis research during the COVID-19 pandemic S. Burnett, M. Preidt, T. FitzMaurice, M. Walshaw, D. Nazareth
94 [GO] 2021―Jun―11 P091 Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic I. Todorić, I. Bambir, I. Markelić, L. Omerza, T. Milinković, T. Odobašić Palković, et al. (+4)
95 [GO] 2021―Jun―11 P090 A UK survey on changes in managing people with cystic fibrosis during the COVID-19 pandemic M.S. Hameed, A. Kumar, C. Baker, D. Nazareth, M. Walshaw
96 [GO] 2021―Jun―11 EPS1.01 Physiotherapy practice of French cystic fibrosis children changed during lockdown due to COVID-19 pandemic M. Mittaine, E. Aversenq, P. Milhorat, C. Lannibois, P. Maumus, A. Arrouy
97 [GO] 2021―Jun―11 WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic K. Richards, S. Geoghegan, M. Butler, N. Shafi, D. Watson
98 [GO] 2021―Jun―11 WS11.1 The anxiety levels of children with cystic fibrosis and healthy children during the COVID-19 pandemic A.P. Ergenekon, M. Cenk, C. Yilmaz Yegit, M. Yuksel, A. Guliyeva, A. Toksoy Aksoy, et al. (+6)
99 [GO] 2021―Jun―11 EPS1.09 Adapting services during the COVID-19 pandemic - a patient evaluation of physiotherapy telephone reviews within multidisciplinary team virtual clinics S. Fitzgerald, C. Lathia, P. Wilson.
100 [GO] 2021―Jun―11 P092 Embedding an electronic patient record into a developing UK service and impact during the COVID-19 pandemic - Blackpool Adult Cystic Fibrosis Service (BACFS) N. Pickering, T. Saba
101 [GO] 2021―Jun―11 P223 The role of psychologist in a cystic fibrosis centre during the COVID-19 pandemic - experience of a Polish paediatric centre U. Borawska-Kowalczyk, A. Sujecka, M. Mielus, D. Sands
102 [GO] 2021―Jun―11 P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre? N. Iqbal, Z. Nadat, J.E. Vessey, K.J. Martin, A.L. Brennan, R.J. Bright-Thomas, et al. (+3)
103 [GO] 2021―Jun―11 P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre L. Warnock, W. Flight, K. Chapman, A. Gates
104 [GO] 2021―Jun―11 WS14.4 Exploring cystic fibrosis patient and staff perceptions of the Virtual Healthcare Hub during the COVID-19 pandemic at the All Wales Adult Cystic Fibrosis Service E. Birkin, C. Bridges, L. Speight, C. O'Leary, J. Duckers
105 [GO] 2021―Jun―11 P221 Quality of life in adult and children with cystic fibrosis during the COVID-19 pandemic in Croatia T. Odobasic Palkovic, T. Milinkovic, I. Markelic, F. Džubur, I. Godic, I. Barbir, et al. (+2)
106 [GO] 2021―Jun―11 P139 Evaluating the impact of a telemedicine service during the COVID-19 pandemic in people with cystic fibrosis A. Bull, T.S. FitzMaurice, D. Nazareth, M. Walshaw
107 [GO] 2021―Jun―11 WS14.1 The effect of the COVID-19 pandemic on quality of life of adults with cystic fibrosis E. Birkin, L. Speight, A. Smith, C. Oleary, J. Duckers
108 [GO] 2021―Jun―11 P219 Before and during the COVID-19 pandemic: a review of health of our paediatric cystic fibrosis patients L. Powell, J. Watkinson, N. Rao
109 [GO] 2021―Jun―11 P224 Change in care during the COVID-19 pandemic: single-centre experience in a middle-income setting E. Hatziagorou, I. Toulia, E. Kalaitzidou, E-A Chrysochoou, M. Galogavrou, J. Tsanakas
110 [GO] 2021―Jun―11 EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK A. Connolly, J. Knowles, M. Etumi
111 [GO] 2021―Jun―11 EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2 C. Schwarz, M. Lackner, P. Eschenhagen, M. Nagl
112 [GO] 2021―Jun―11 WS14.5 SARS-CoV-2 driving rapid change in cystic fibrosis services: the role of the clinical nurse specialist R. Dunk, S. Madge
113 [GO] 2021―Jun―11 P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group C. Colombo, G. Alicandro, V. Daccó, V. Gagliano, L.C. Morlacchi, R. Casciaro, et al. (+11)
114 [GO] 2021―Jun―11 P135 SARS-COV-2 infection in patients with cystic fibrosis L. Balanetchi, E. Gudumac, D. Rotaru-Cojocari, R. Selevestru, S. Sciuca
115 [GO] 2021―Jun―11 P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study E. McClenaghan, R. Cosgriff, K. Brownlee, S. Ahern, P.-R. Burgel, C.A. Byrnes, et al. (+29)
116 [GO] 2021―Jun―11 P231 Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England A. Sanderson-Thomas, N. Pickering, T. Saba
117 [GO] 2021―Jun―11 P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany D. Dolce, N. Ravenni, M. Francalanci, S. Campana, E. Camera, G. Mergni, et al. (+6)
118 [GO] 2021―Jun―11 P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020 S. Van Koningsbruggen-Rietschel, V. Bulteel, F. Dunlevy, K. Hayes, A. Verbrugge, D. Downey
119 [GO] 2021―Jun―11 P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry H. Rees, S. Babu, G. Fletcher, L. Kirwan
120 [GO] 2021―Jun―11 P222 Supporting children with cystic fibrosis: building social networks through the pandemic E. Lee Mindel
121 [GO] 2021―Jun―11 P140 TeCC (TeleMedicine, Cystic Fibrosis, Corona-Virus) study in a previous telemedicine-naive centre: clinical challenges, outcomes, and user experience in the first six months of a global pandemic D. Morrissy, T. Vagg, M. McCarthy, J. Dorgan, C. Fleming, C. Howlett, et al. (+2)
122 [GO] 2021―Jun―11 P051 Rollout of Kaftrio® to adult cystic fibrosis patients at the Royal Brompton Hospital during a global pandemic E. Bowman, C. Caldwell, A. Jones, S. Madge
123 [GO] 2021―Jun―11 P203 Fertile ground: pregnancies in a post-Kaftrio® pandemic era A. Lillis, S. Lorca-Mayor, P. Weldon, E. Marsh, S. Collins, C. Lathia, et al. (+5)
124 [GO] 2021―Jun―05 Speaking of pandemics... Michael S. Schechter
125 [GO] 2021―Apr―19 Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 Naehrlich Lutz, Orenti Annalisa, Dunlevy Fiona, Kasmi Irena, Harutyunyan Satenik, Pfleger Andreas, et al. (+64)
126 [GO] 2021―Apr―16 COVID-19 vaccine prioritisation for people with cystic fibrosis Siobhán B Carr, Rebecca Cosgriff, Satenik Harutyunyan, Peter G Middleton, Rasa Ruseckaite, Susannah Ahern, et al. (+32)
127 [GO] 2021―Apr―08 SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: an unfavourable conjunction? C. Olcese, R. Casciaro, D. Pirlo, C. Debbia, E. Castagnola, F. Cresta, C. Castellani
128 [GO] 2021―Mar―27 Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19 Davis Jaclyn, NeSmith Andrew, Perkins Ryan, Bailey Julianna, Siracusa Christopher, Chaudary Nauman, et al. (+3)
129 [GO] 2021―Jan―26 To the Editor of Journal of Cystic Fibrosis: First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: data from Italian Cystic Fibrosis Registry Rita Padoan, Marco Salvatore
130 [GO] 2020―Dec―23 PSYCHOLOGICAL DISTRESS IN ADULTS WITH AND WITHOUT CYSTIC FIBROSIS DURING THE COVID-19 LOCKDOWN Riccardo Ciprandi, Maurizio Bonati, Rita Campi, Rita Pescini, Carlo Castellani
131 [GO] 2020―Dec―17 The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network Kelsie Pearson, Nicole Mayer-Hamblett, Christopher H. Goss, George Z. Retsch-Bogart, Jill M. VanDalfsen, Patricia Burks, et al. (+4)
132 [GO] 2020―Dec―03 Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study Robert Bain, Rebecca Cosgriff, Marco Zampoli, Alexander Elbert, Pierre-Régis Burgel, Siobhán B Carr, et al. (+19)
133 [GO] 2020―Nov―20 ALPHA-1 ANTITRYPSIN FOR CYSTIC FIBROSIS COMPLICATED BY SEVERE CYTOKINEMIC COVID-19 Oliver J McElvaney, Eoin O'Connor, Natalie L McEvoy, Daniel D Fraughan, Jennifer Clarke, Oisín F McElvaney, et al. (+4)
134 [GO] 2020―Nov―05 The global impact of SARS-CoV-2 in 181 people with cystic fibrosis Elliot McClenaghan, Rebecca Cosgriff, Keith Brownlee, Susannah Ahern, Pierre-Régis Burgel, Catherine A Byrnes, et al. (+27)
135 [GO] 2020―Aug―28 Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis Thomas Radtke, Sarah R. Haile, Holger Dressel, Christian Benden
136 [GO] 2020―Aug―11 SARS-CoV-2 seroprevalence in a belgian cohort of patients with cystic fibrosis S. Berardis, A. Verroken, A. Vetillart, C. Struyf, M. Gilbert, D. Gruson, S. Gohy
137 [GO] 2020―Jul―31 The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients. Trudy Havermans, Janne Houben, Francois Vermeulen, Mieke Boon, Marijke Proesmans, Natalie Lorent, et al. (+3)
138 [GO] 2020―Jun―23 No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy Carolina Scagnolari, Camilla Bitossi, Federica Frasca, Agnese Viscido, Giuseppe Oliveto, Mirko Scordio, et al. (+6)
139 [GO] 2020―Jun―08 Healthcare reassessment in a pandemics time: challenges for CF Carlo Castellani
140 [GO] 2020―May―11 COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful Eric Farfour, Clément Picard, Laurence Beaumont, Philippe Lesprit, Marie-Christine Ballester, Felix Ackermann, et al. (+4)
141 [GO] 2020―Apr―25 A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS Rebecca Cosgriff, Susannah Ahern, Scott C. Bell, Keith Brownlee, Pierre-Régis Burgel, Cass Byrnes, et al. (+12)
142 [GO] 2020―Apr―13 Asymptomatic case of Covid-19 in an infant with cystic fibrosis Piercarlo Poli, Silviana Timpano, Martina Goffredo, Rita Padoan, Raffaele Badolato

142 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec